CONFERENCE
Date: October 2012
City: Nice, France
Event type: Round Table
REGISTER NOW
|
|
Biopharm Reports
Biopharm Reports provides market research services to the pharmaceutical and biomedical industries and publishes global reviews on markets, developments and pipeline. It is an independent commercial research company that carries out assessments of products, technologies and services. Biopharm Reports uses primary research methods to ensure that their findings are accurate, current and reliable.
Biopharm Reports supplies with information to help companies compete more effectively in the marketplace, differentiating themselves from their competitors. The company evaluates both markets and people important to customers’ business development plans.
- Market Reports
- News & Press-Releases
Antibiotic Resistance 2012: The Antibiotic Development Pipeline and Strategies to Combat Antibiotic Resistance
Jan, 2012 · 120 pages
|
US$ 2,300.00 |
Salient Review Non-Small Cell Lung Cancer: Advances in Blood Biomarkers, 2011
Oct, 2011 · 60 pages
|
US$ 515.00 |
Salient Review Colorectal Cancer: Advances in Blood Biomarkers, 2011
Oct, 2011 · 60 pages
|
US$ 515.00 |
VEGF Inhibition: Therapy-Indicating and Prognostic Biomarkers, 2011
Oct, 2011 · 97 pages
|
US$ 988.00 |
Lung Cancer Therapeutic Antibodies: Pipeline, Strategies and Clinical
Oct, 2011 · 135 pages
|
US$ 1,200.00 |
Lung Cancer Vaccines: Pipeline, Strategies and Clinical
Oct, 2011 · 135 pages
|
US$ 1,520.00 |
Lung Cancer Vaccines and Therapeutic Antibodies: Pipeline, Strategies and Clinical
Oct, 2011 · 186 pages
|
US$ 2,384.00 |
Prostate Cancer Vaccines and Therapeutic Antibodies: Pipeline, 2011
Feb, 2010 · 95 pages
|
US$ 2,384.00 |
Peripheral Neuropathy and Neuropathic Pain, 2008: Current, pipeline and emerging drugs for the treatment of peripheral neuropathy and neuropathic pain
Jun, 2009 · 105 pages
|
US$ 2,384.00 |
Image-Based Biomarkers in Alzheimer's Disease, 2011
Feb, 2010 · 61 pages
|
US$ 880.00 |
Breast Cancer Vaccines and Therapeutic Antibodies: Pipeline, 2011
Feb, 2010 · 95 pages
|
US$ 2,384.00 |
Biomarkers in Breast Cancer, 2011
Jan, 2010 · 195 pages
|
US$ 2,384.00 |
Alzheimer's Disease: Markets, Pipeline and Opportunities 2009
Apr, 2009 · 110 pages
|
US$ 2,384.00 |
Alzheimer's Disease: Autoantibodies, Vaccines and Therapeutic Antibodies Pipeline, 2011
Mar, 2010 · 115 pages
|
US$ 2,384.00 |
Alzheimer's Disease Biomarkers in Cerebrospinal Fluid and Blood, 2011
Feb, 2010 · 89 pages
|
US$ 1,648.00 |
Biomarkers in Parkinson's Disease, 2011
Jan, 2010 · 105 pages
|
US$ 2,384.00 |
Antibiotics and Drug Resistance 2008
Mar, 2008 · 174 pages
|
US$ 2,384.00 |
Cancer Drug Resistance
Jan, 2009 · 235 pages
|
US$ 2,384.00 |
Hypertension: Competing Treatments and Market Entry Considerations
Jun, 2010 · 225 pages
|
US$ 3,984.00 |
Stroke: Competing Treatments and Market Entry Considerations
Jun, 2010 · 140 pages
|
US$ 3,984.00 |
Treating Neuropathic Pain - A Global Study of Clinical Strategies
Jan, 2010 · 195 pages
|
US$ 3,000.00 |
Targeting Cancer Stem Cells: Therapeutic Strategies, Pipeline, Biomarkers and Opportunities
Jan, 2010 · 124 pages
|
US$ 2,384.00 |
Neuropathic Pain: Competing Treatments and Market Entry Considerations
Jun, 2010 · 195 pages
|
US$ 3,984.00 |
Biomarkers in Alzheimer's Disease, 2011
Apr, 2011 · 175 pages
|
US$ 2,384.00 |
Alzheimer's Disease: Competing Treatments and Market Entry Considerations
Jun, 2010 · 114 pages
|
US$ 2,384.00 |
|
|
